Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes

详细信息    查看全文

• 作者：Michelle R. Peace^a ; ^{mrpeace@vcu.edu} ; Rose I. Krakowiak^a ; ^{krakowiakr@mymail.vcu.edu} ; Carl E. Wolf^a ; ^b ; ^{carl.wolf@vcuhealth.org} ; Alphonse Poklis^a ; ^b ; ^c ; ^{alphones.poklis@vcuhealth.org} ; Justin L. Poklis^c ; ^{justin.poklis@vcuhealth.org}
• 关键词：Electronic cigarette ; MDMB-FUBINACA ; E-liquids ; Designer drugs ; Cannabimimetics
• 刊名：Forensic Science International
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：271
• 期：Complete
• 页码：92-97
• 全文大小：1203 K
• 卷排序：271

文摘

Three commercially available e-liquids were analyzed by DART-MS, GC–MS, SPME–GC–MS and HS-GC–FID for their contents. MDMB-FUBINACA, a cannabimimetic drug, was found to be the major active ingredient. MDMB-FUBINACA was successfully aerosolized by an electronic cigarette. Ethanol and numerous flavorants were also detected in the e-liquids.